Harvard Ave Acquisition Corporation Unit
NASDAQ:HAVAUShell Companies
-$0.00 today
- Market cap
- $153.15M
- Beta
- 0.03
- P/E (TTM)
- 194.6
- EPS (TTM)
- $0.05
Volume 0.00M
Average 0.00M
HAVAU Deferred Income Tax
The difference between tax expense recognized and tax actually paid in cash during the period.
Harvard Ave Acquisition Corporation UnitNASDAQ: HAVAU
Deferred Income Tax · Q1 FY2026 · quarter ended Mar 2026
Deferred income tax outflow grows to $0
Q1 FY2026 deferred income tax was $0, compared with $0 a year earlier.
Sources:Cash FlowText generated from reported figures; not investment advice.
Deferred Income Tax history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Income Tax | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
Deferred Income Tax vs competitors
How HAVAU compares with its peers on the latest reported figures
- HAVAU's FY2025 deferred income tax of $0 is the 2nd largest of the 7 companies compared; the peer median is $0.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Dec 2025 | $273K | +78.4% | +2.5% | 0.9% | |
HAVAUHarvard Ave Acquisition Corporation Unit | FY2025 | $0 | — | — | — |
KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary Shares | FY2025 | $0 | — | — | — |
EURKEureka Acquisition Corp Class A Ordinary Share | LTM Mar 2026 | $0 | — | — | — |
BSAABEST SPAC I Acquisition Corp. | FY2025 | $0 | — | — | — |
AFJKAimei Health Technology Co., Ltd | LTM Mar 2026 | $0 | — | — | — |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding HAVAU) | $0 | +78.4% | +2.5% | 0.9% | |
Competitors are the stored peer set for HAVAU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Net Income | (62) | 252.9K |
| Depreciation & Amortization | 0 | 0 |
| Deferred Income Tax | 0 | 0 |
| Stock-Based Compensation | 0 | 0 |
| Change in Working Capital | 21 | 0 |
| Accounts Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Accounts Payables | 0 | 0 |
| Other Working Capital | 21 | 0 |
| Other Non-Cash Items | 37 | (1.56M) |
| Operating Cash Flow | (4) | (1.31M) |
| Capital Expenditures | 4 | 0 |
| Acquisitions (Net) | 0 | 0 |
| Purchases of Investments | 0 | 0 |
| Sales of Investments | 0 | 0 |
| Other Investing Activities | 0 | (145M) |
| Investing Cash Flow | 0 | (145M) |
| Debt Repayment | 9 | 0 |
| Common Stock Issued | 0 | 0 |
| Common Stock Repurchased | 0 | 0 |
| Dividends Paid | 0 | 0 |
| Other Financing Activities | 0 | 146.31M |
| Financing Cash Flow | 8 | 146.31M |
| Effect of Forex Changes | 0 | 0 |
| Net Change in Cash | 4 | 0 |
| Free Cash Flow | 0 | (1.31M) |
Harvard Ave Acquisition Corporation Unit
NASDAQ:HAVAU
Intrinsic Alpha fair value
Locked
Current Price
$10.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.